Skip to main content
. 2021 Aug;15(8):247–254. doi: 10.5489/cuaj.7492

Table 5.

Detailed description of quantitative patient alpha-testing results specific to each section of the patient decision aid (n=19)

Questions Small to moderate prostate volumes (<80 ml) (n=11) Moderate to large prostate volumes (80–150 ml) (n=5) Large prostate volumes (>150 ml) (n=3)

n (%) n (%) n (%)
 1 The amount of information provided was: Much less than wanted
A little less than wanted 2 (40.0%) 1 (33.33%)
About right 11 (100%) 3 (60.0%) 2 (66.67%)
A little more than wanted
Much more than wanted
 2 The length of the PtDA was: Too short 1 (33.33%)
Just right 9 (81.82%) 5 (100.0%) 2 (66.67%)
Too long 2 (18.18%)
 3 The language used was easy to follow: Strongly disagree
Disagree
Neutral
Agree 3 (27.27%) 1 (20.0%) 2 (66.67%)
Strongly agree 8 (72.73%) 4 (80.0%) 1 (33.33%)
 4 The outcomes reported were easy to follow: Strongly disagree
Disagree
Neutral 2 (18.18%)
Agree 6 (54.55%) 3 (60.0%) 2 (66.67%)
Strongly agree 3 (27.27%) 2 (40.0%) 1 (33.33%)

Section for all prostate volumes

Questions n (%) n (%) n (%)

 5 This decision aid would have been helpful during my treatment decision-making: Strongly disagree
Disagree
Neutral 1 (9.09%) 1 (33.33%)
Agree 4 (36.37%) 4 (80.0%)
Strongly agree 6 (54.54%) 1 (20.0%) 2 (66.67%)
 6 I would recommend this decision aid for new patients with BPH: Strongly disagree
Disagree
Neutral
Agree 3 (27.27%) 2 (40.0%)
Strongly agree 8 (72.73%) 3 (60.0%) 3 (100%)
 7 I am satisfied with the overall quality of this PtDA: Strongly disagree
Disagree
Neutral
Agree 3 (27.27%) 2 (40.0%) 2 (66.67%)
Strongly agree 8 (72.73%) 3 (60.0%) 1 (33.33%)

BPH: benign prostatic hyperplasia; PtDA: patient decision aid.